Loading…

Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies

Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validatio...

Full description

Saved in:
Bibliographic Details
Published in:Rapid communications in mass spectrometry 2009-01, Vol.23 (2), p.258-266
Main Authors: Teichert, Friederike, Verschoyle, Richard D., Greaves, Peter, Thorpe, James F., Mellon, J. Kilian, Steward, William P., Farmer, Peter B., Gescher, Andreas J., Singh, Rajinder
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873
cites cdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873
container_end_page 266
container_issue 2
container_start_page 258
container_title Rapid communications in mass spectrometry
container_volume 23
creator Teichert, Friederike
Verschoyle, Richard D.
Greaves, Peter
Thorpe, James F.
Mellon, J. Kilian
Steward, William P.
Farmer, Peter B.
Gescher, Andreas J.
Singh, Rajinder
description Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p 
doi_str_mv 10.1002/rcm.3873
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_901667630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>35353411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</originalsourceid><addsrcrecordid>eNp90UGP1CAUAGBiNO7sauIvMJzUS3eh0NJ624y6a7JqNBtNvBBaXnfQAl1o1-nNP-TFn-QvkbGjnjQc4PE-XoCH0ANKjikh-Ulo7TGrBLuFVpTUIiM5o7fRitQFzTitqwN0GOMnQigtcnIXHdCaiLwq2Qp9ewYjBGucGo132He4yvzWZ_mPr98zDX47X03K-WgcYOU0bgMk6XahcdhO4XdiM1nl8BI3M-7N9WQS3wRv1eivgho288mYJFhsVYw4DtCOKQtjmJ9iNQy9aZdLjD6dA-uHADfgfm3FcdIG4j10p1N9hPv7-Qhdvnh-uT7PLt6cvVyfXmQtT6_KFADvVKdz6ERZsq5mbZVzWnKtlRBNydKi1jpvGq5EThqqGSUFbyg0QqRvPEKPl7JD8NcTxFFaE1voe-XAT1HWhJalKBlJ8tF_JSvS4JQm-GSBbfAxBujkEIxVYZaUyF0PZeqh3PUw0Yf7mlNjQf-F-6YlkC3gi-lh_mch-W79al9w700cYfvHq_BZloKJQn54fSbfv11_5OeMSc5-AmlcurQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>35353411</pqid></control><display><type>article</type><title>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Teichert, Friederike ; Verschoyle, Richard D. ; Greaves, Peter ; Thorpe, James F. ; Mellon, J. Kilian ; Steward, William P. ; Farmer, Peter B. ; Gescher, Andreas J. ; Singh, Rajinder</creator><creatorcontrib>Teichert, Friederike ; Verschoyle, Richard D. ; Greaves, Peter ; Thorpe, James F. ; Mellon, J. Kilian ; Steward, William P. ; Farmer, Peter B. ; Gescher, Andreas J. ; Singh, Rajinder</creatorcontrib><description>Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p &lt; 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8‐oxodG and creatinine in urine samples from both clinical and pre‐clinical studies. Copyright © 2008 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0951-4198</identifier><identifier>ISSN: 1097-0231</identifier><identifier>EISSN: 1097-0231</identifier><identifier>DOI: 10.1002/rcm.3873</identifier><identifier>PMID: 19072863</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Adenocarcinoma - urine ; Animals ; Antineoplastic Agents - administration &amp; dosage ; Antineoplastic Agents - pharmacokinetics ; Cell Line, Tumor ; Chromatography, High Pressure Liquid - methods ; Creatinine - urine ; Deoxyguanosine - analogs &amp; derivatives ; Deoxyguanosine - urine ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Plant Extracts - administration &amp; dosage ; Plant Extracts - pharmacokinetics ; Prostatic Neoplasms - urine ; Reproducibility of Results ; Sensitivity and Specificity ; Spectrometry, Mass, Electrospray Ionization - methods ; Tea - chemistry ; Urinalysis - methods</subject><ispartof>Rapid communications in mass spectrometry, 2009-01, Vol.23 (2), p.258-266</ispartof><rights>Copyright © 2008 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright (c) 2008 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</citedby><cites>FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19072863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teichert, Friederike</creatorcontrib><creatorcontrib>Verschoyle, Richard D.</creatorcontrib><creatorcontrib>Greaves, Peter</creatorcontrib><creatorcontrib>Thorpe, James F.</creatorcontrib><creatorcontrib>Mellon, J. Kilian</creatorcontrib><creatorcontrib>Steward, William P.</creatorcontrib><creatorcontrib>Farmer, Peter B.</creatorcontrib><creatorcontrib>Gescher, Andreas J.</creatorcontrib><creatorcontrib>Singh, Rajinder</creatorcontrib><title>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</title><title>Rapid communications in mass spectrometry</title><addtitle>Rapid Commun. Mass Spectrom</addtitle><description>Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p &lt; 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8‐oxodG and creatinine in urine samples from both clinical and pre‐clinical studies. Copyright © 2008 John Wiley &amp; Sons, Ltd.</description><subject>Adenocarcinoma - urine</subject><subject>Animals</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Cell Line, Tumor</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Creatinine - urine</subject><subject>Deoxyguanosine - analogs &amp; derivatives</subject><subject>Deoxyguanosine - urine</subject><subject>Humans</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Plant Extracts - administration &amp; dosage</subject><subject>Plant Extracts - pharmacokinetics</subject><subject>Prostatic Neoplasms - urine</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Spectrometry, Mass, Electrospray Ionization - methods</subject><subject>Tea - chemistry</subject><subject>Urinalysis - methods</subject><issn>0951-4198</issn><issn>1097-0231</issn><issn>1097-0231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp90UGP1CAUAGBiNO7sauIvMJzUS3eh0NJ624y6a7JqNBtNvBBaXnfQAl1o1-nNP-TFn-QvkbGjnjQc4PE-XoCH0ANKjikh-Ulo7TGrBLuFVpTUIiM5o7fRitQFzTitqwN0GOMnQigtcnIXHdCaiLwq2Qp9ewYjBGucGo132He4yvzWZ_mPr98zDX47X03K-WgcYOU0bgMk6XahcdhO4XdiM1nl8BI3M-7N9WQS3wRv1eivgho288mYJFhsVYw4DtCOKQtjmJ9iNQy9aZdLjD6dA-uHADfgfm3FcdIG4j10p1N9hPv7-Qhdvnh-uT7PLt6cvVyfXmQtT6_KFADvVKdz6ERZsq5mbZVzWnKtlRBNydKi1jpvGq5EThqqGSUFbyg0QqRvPEKPl7JD8NcTxFFaE1voe-XAT1HWhJalKBlJ8tF_JSvS4JQm-GSBbfAxBujkEIxVYZaUyF0PZeqh3PUw0Yf7mlNjQf-F-6YlkC3gi-lh_mch-W79al9w700cYfvHq_BZloKJQn54fSbfv11_5OeMSc5-AmlcurQ</recordid><startdate>20090130</startdate><enddate>20090130</enddate><creator>Teichert, Friederike</creator><creator>Verschoyle, Richard D.</creator><creator>Greaves, Peter</creator><creator>Thorpe, James F.</creator><creator>Mellon, J. Kilian</creator><creator>Steward, William P.</creator><creator>Farmer, Peter B.</creator><creator>Gescher, Andreas J.</creator><creator>Singh, Rajinder</creator><general>John Wiley &amp; Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7ST</scope><scope>C1K</scope><scope>SOI</scope></search><sort><creationdate>20090130</creationdate><title>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</title><author>Teichert, Friederike ; Verschoyle, Richard D. ; Greaves, Peter ; Thorpe, James F. ; Mellon, J. Kilian ; Steward, William P. ; Farmer, Peter B. ; Gescher, Andreas J. ; Singh, Rajinder</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adenocarcinoma - urine</topic><topic>Animals</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Cell Line, Tumor</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Creatinine - urine</topic><topic>Deoxyguanosine - analogs &amp; derivatives</topic><topic>Deoxyguanosine - urine</topic><topic>Humans</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Plant Extracts - administration &amp; dosage</topic><topic>Plant Extracts - pharmacokinetics</topic><topic>Prostatic Neoplasms - urine</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Spectrometry, Mass, Electrospray Ionization - methods</topic><topic>Tea - chemistry</topic><topic>Urinalysis - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teichert, Friederike</creatorcontrib><creatorcontrib>Verschoyle, Richard D.</creatorcontrib><creatorcontrib>Greaves, Peter</creatorcontrib><creatorcontrib>Thorpe, James F.</creatorcontrib><creatorcontrib>Mellon, J. Kilian</creatorcontrib><creatorcontrib>Steward, William P.</creatorcontrib><creatorcontrib>Farmer, Peter B.</creatorcontrib><creatorcontrib>Gescher, Andreas J.</creatorcontrib><creatorcontrib>Singh, Rajinder</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Environment Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><jtitle>Rapid communications in mass spectrometry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teichert, Friederike</au><au>Verschoyle, Richard D.</au><au>Greaves, Peter</au><au>Thorpe, James F.</au><au>Mellon, J. Kilian</au><au>Steward, William P.</au><au>Farmer, Peter B.</au><au>Gescher, Andreas J.</au><au>Singh, Rajinder</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</atitle><jtitle>Rapid communications in mass spectrometry</jtitle><addtitle>Rapid Commun. Mass Spectrom</addtitle><date>2009-01-30</date><risdate>2009</risdate><volume>23</volume><issue>2</issue><spage>258</spage><epage>266</epage><pages>258-266</pages><issn>0951-4198</issn><issn>1097-0231</issn><eissn>1097-0231</eissn><abstract>Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p &lt; 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8‐oxodG and creatinine in urine samples from both clinical and pre‐clinical studies. Copyright © 2008 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>19072863</pmid><doi>10.1002/rcm.3873</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0951-4198
ispartof Rapid communications in mass spectrometry, 2009-01, Vol.23 (2), p.258-266
issn 0951-4198
1097-0231
1097-0231
language eng
recordid cdi_proquest_miscellaneous_901667630
source Wiley-Blackwell Read & Publish Collection
subjects Adenocarcinoma - urine
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacokinetics
Cell Line, Tumor
Chromatography, High Pressure Liquid - methods
Creatinine - urine
Deoxyguanosine - analogs & derivatives
Deoxyguanosine - urine
Humans
Male
Mice
Mice, Inbred C57BL
Plant Extracts - administration & dosage
Plant Extracts - pharmacokinetics
Prostatic Neoplasms - urine
Reproducibility of Results
Sensitivity and Specificity
Spectrometry, Mass, Electrospray Ionization - methods
Tea - chemistry
Urinalysis - methods
title Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A29%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%208-oxo-2%E2%80%B2-deoxyguanosine%20and%20creatinine%20in%20murine%20and%20human%20urine%20by%20liquid%20chromatography/tandem%20mass%20spectrometry:%20application%20to%20chemoprevention%20studies&rft.jtitle=Rapid%20communications%20in%20mass%20spectrometry&rft.au=Teichert,%20Friederike&rft.date=2009-01-30&rft.volume=23&rft.issue=2&rft.spage=258&rft.epage=266&rft.pages=258-266&rft.issn=0951-4198&rft.eissn=1097-0231&rft_id=info:doi/10.1002/rcm.3873&rft_dat=%3Cproquest_cross%3E35353411%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=35353411&rft_id=info:pmid/19072863&rfr_iscdi=true